TCM
DFTX

Tang Capital Management’s Definium Therapeutics DFTX Stock Holding History

Tang Capital Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-600,200
Closed -$7.08M – 149
2025
Q3 		$7.08M Hold
600,200
– – 0.27% 79
2025
Q2 		$3.9M Buy
600,200
+200,000
+50% +$1.32M 0.2% 93
2025
Q1 		$2.34M Buy
400,200
+200,200
+100% +$1.43M 0.13% 108
2024
Q4 		$1.39M Buy
+200,000
New +$1.38M 0.09% 120
2024
Q2 		– Sell
-300,000
Closed -$2.82M – 134
2024
Q1 		$2.82M Buy
+300,000
New +$1.71M 0.29% 71

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Tang Capital Management's DFTX Position: Q4 2025 in Review

Tang Capital Management sold out of Definium Therapeutics (DFTX) in Q4 2025, closing a stake of 600,200 shares — an estimated $7.08M sold.

Tang Capital Management first reported a position in DFTX in Q1 2024 and held it in 5 quarters. The position peaked at $7.08M in Q3 2025. 208 funds tracked by Wall St. Rank hold DFTX as of Q4 2025.

  • Tang Capital Management reported no remaining Definium Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Tang Capital Management sold 600,200 Definium Therapeutics shares in Q4 2025, an estimated $7.08M.
  • Tang Capital Management first reported a position in Definium Therapeutics in Q1 2024 and held it in 5 quarters.
  • Tang Capital Management's Definium Therapeutics position peaked at $7.08M in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Definium Therapeutics as of Q4 2025.

Based on Tang Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.